Jeevan Scientific Technology Stock Screener | Share Price & Fundamental Analysis
JSTL
Healthcare Technology
Screen Jeevan Scientific Technology share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹68.05
▲
3.05 (4.69%)
Market Cap
₹102.95 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.13
EPS (TTM)
₹-0.04
Dividend Yield
-
Debt to Equity
0.35
52W High
₹68.05
52W Low
₹33.98
Operating Margin
-4.00%
Profit Margin
-10.00%
Revenue (TTM)
₹10.00
EBITDA
-
Net Income
₹-1.00
Total Assets
₹78.00
Total Equity
₹50.00
Jeevan Scientific Technology Share Price History - Stock Screener Chart
Screen JSTL historical share price movements with interactive charts. Analyze price trends and patterns.
Jeevan Scientific Technology Company Profile - Fundamental Screener
Screen Jeevan Scientific Technology company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JSTL shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE237B01018
Jeevan Scientific Technology Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen JSTL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 78 | 68 | 66 | 78 | 66 | 54 | 61 | 49 | 31 | 20 |
| Current Assets | 29 | 25 | 29 | 54 | 34 | 18 | 25 | 21 | 14 | 11 |
| Fixed Assets | 35 | 27 | 25 | 19 | 27 | 31 | 33 | 28 | 16 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 78 | 68 | 66 | 78 | 66 | 54 | 61 | 49 | 31 | 20 |
| Current Liabilities | 16 | 10 | 6 | 5 | 8 | 8 | 8 | 10 | 5 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 50 | 49 | 48 | 51 | 35 | 23 | 32 | 22 | 17 | 4 |
| Share Capital | 16 | 16 | 16 | 15 | 15 | 15 | 15 | 12 | 9 | 6 |
| Reserves & Surplus | 34 | 33 | 33 | 35 | 20 | 8 | 17 | 7 | 3 | -2 |
Screen JSTL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 9 | 13 | 11 | 13 | 12 | 13 | 8 | 11 | 8 | 10 | 17 | 11 | 8 | 10 |
| Expenses | 10 | 11 | 10 | 10 | 10 | 9 | 10 | 9 | 8 | 8 | 9 | 14 | 9 | 8 | 9 |
| EBITDA | 0 | -1 | 2 | 1 | 3 | 3 | 2 | -1 | 2 | 1 | 1 | 3 | 2 | 0 | 2 |
| Operating Profit % | -4.00% | -20.00% | 17.00% | 9.00% | 25.00% | 22.00% | 17.00% | -13.00% | 20.00% | 7.00% | 10.00% | -18.00% | 12.00% | -5.00% | 15.00% |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -3 | -4 | 0 | -1 | 2 | 1 | 0 | -3 | 1 | -1 | -1 | 2 | 0 | -2 | 0 |
| Tax | -1 | -1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Net Profit | -1 | -3 | 0 | -1 | 1 | 0 | 0 | -2 | 1 | -1 | -1 | 1 | 0 | -1 | 0 |
| EPS | -0.81 | -2.03 | 0.01 | -0.47 | 0.66 | 0.16 | 0.03 | -1.51 | 0.33 | -0.39 | -0.31 | 0.52 | 0.25 | -0.78 | 0.04 |
Jeevan Scientific Technology Cash Flow Screener - Liquidity Fundamentals
Screen JSTL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | 3 | -6 | 20 | 5 | 0 | 4 | 6 | -6 | 4 |
| Investing Activities | -16 | -12 | -7 | -1 | -1 | -2 | -8 | -14 | -9 | -4 |
| Financing Activities | 5 | 2 | -10 | 6 | 0 | 0 | 6 | 10 | 15 | 0 |
| Net Cash Flow | 0 | -6 | -23 | 24 | 4 | -2 | 2 | 1 | 0 | 0 |
Screen JSTL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 38.05% | 38.05% | 38.05% | 37.84% | 38.70% | 38.70% | 38.70% | 38.48% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 42.76% | 42.75% | 42.99% | 45.91% | 45.75% | 45.34% | 45.50% | 45.51% |
| Other Holding | 19.19% | 19.21% | 18.96% | 16.25% | 15.55% | 15.96% | 15.80% | 16.00% |
| Shareholder Count | 5,444 | 5,460 | 5,497 | 5,565 | 5,607 | 5,655 | 5,749 | 5,727 |
Jeevan Scientific Technology Dividend Screener - Share Yield Analysis
Screen JSTL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.20 | 2.38% |
| 2021-March | ₹0.50 | 0.38% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Jeevan Scientific Technology Index Membership - Market Screener Classification
Screen JSTL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Jeevan Scientific Technology Market Events Screener - Corporate Actions
Screen JSTL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -8.88% | ||
| Dividend | ₹ 1.20 /share | -20.11% | ||
| Dividend | ₹ 0.50 /share | -1.73% | ||
| 2025-11-12 | 2025-11-12 | Extraordinary General Meeting | NA | 7.67% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -4.42% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 7.49% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.73% |
| 2025-03-27 | 2025-03-27 | Extraordinary General Meeting | NA | -3.79% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 0.42% |
| 2024-11-08 | 2024-11-08 | Quarterly Result Announcement | NA | -0.11% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 11.55% |
Jeevan Scientific Technology Competitors Screener - Peer Comparison
Screen JSTL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 26,491 | 55.90 | 3,714 | 3.77% | 496 | 51.46 |
| Indegene | 12,561 | 28.01 | 2,947 | 10.53% | 407 | 42.94 |
| Suven Life Sciences | 3,776 | -17.74 | 18 | -46.34% | -161 | 39.99 |
| Vimta Labs | 2,704 | 43.62 | 322 | 0.22% | 41 | 44.90 |
| Take Solutions | 599 | 12.37 | 10 | 126.67% | 1 | 87.87 |
| Bilcare | 185 | -4.17 | 807 | 4.78% | -56 | 43.28 |
| Jeevan Scientific Technology | 103 | -22.71 | 48 | 17.87% | 0 | 62.49 |
| Adeshwar Meditex | 26 | 33.09 | 84 | 5.00% | 2 | 21.16 |
| Vanta Bioscience | 17 | -1.26 | 2 | -78.57% | -13 | 20.40 |
Jeevan Scientific Technology Company Announcements - News Screener
Screen JSTL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-03 | Update on board meeting | View |
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-29 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 30-12-2025. | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-12 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-12 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-11-12 | Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 12.11.2025 | View |
| 2025-11-07 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 12.11.2025 | View |
| 2025-11-07 | Corporate Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 About The Completion Of US FDA Remote Interactive Evaluation (RIE) Of JSTL. | View |
| 2025-10-18 | Extra-Ordinary General Meeting Of The Company To Be Held On Wednesday 12Th Day Of November 2025 At 10.00 A.M. Through Video Conference / Other Audio-Visual Means (VC/OAVM) | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-15 | Announcement under Regulation 30 (LODR)-Preferential Issue | View |
| 2025-10-15 | Board Meeting Outcome for Outcome Of Board Meeting Held On 15.10.2025 | View |
| 2025-10-10 | Board Meeting Intimation for Prior Intimation Of Board Meeting For Consideration Of Fund-Raising Proposal | View |
| 2025-10-06 | Announcement under Regulation 30 (LODR)-Retirement | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |